Skip to main content
. Author manuscript; available in PMC: 2010 Dec 10.
Published in final edited form as: Vaccine. 2009 Oct 12;28(1):140–147. doi: 10.1016/j.vaccine.2009.09.086

Figure 2. Anti-VacV neutralizing antibody kinetics.

Figure 2

VacV neutralizing antibody titers (PRNT50) from intact serum sample (closed circles) and IgM depleted serum samples (open squares) were determined by testing daily serum samples after VacV infection. N = 4/group. Total vs IgM depleted samples at day 4 post-infection, P = 0.0153. **, P < 0.01. *, P < 0.05. Error bars represent SEM. Dotted line indicates LOD. Data is representative of 2 independent time course experiments.